The All of Us Research Project is a groundbreaking initiative led by the National Institutes of Health (NIH) in the United States. It aims to gather data from at least one million people living in the U.S. to accelerate research and improve health outcomes for everyone.
One important goal of the study is to sequence the genomes of the participants, in a process known as whole-genome sequencing (WGS). Historically, the majority of genomic data has been collected from only a small subset of groups, especially people of European descent; thus, the development of personalized medicine has largely been driven by data from these groups. Now, in order to help create a more equitable future for precision medicine, the NIH researchers have sequenced the genomes of a much more diverse set of participants, including populations that have often been under-represented in genomics research.
The most recent sequencing data from the project, published in February of 2024 in Nature, includes a summary of clinical-grade whole-genome data for 245,388 individuals. The data reveal that 77% of these are from groups that are historically under-represented in biomedical research, including 51.1% of non-European ancestry and 46% from racial and ethnic minorities.1